File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Hepatocellular carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

TitleHepatocellular carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
Authors
Issue Date2010
PublisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/
Citation
Journal Of Clinical Oncology, 2010, v. 28 n. 25, p. 3994-4005 How to Cite?
AbstractHepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in adults and the third most common cause of cancer death worldwide. The incidence of HCC in the United States is rising steadily because of the prevalence of hepatitis C viral infection and other causes of hepatic cirrhosis. The majority of patients have underlying hepatic dysfunction, which complicates patient management and the search for safe and effective therapies. The Clinical Trials Planning Meeting (CTPM) in HCC was convened by the National Cancer Institute's Gastrointestinal Cancer Steering Committee to identify the key knowledge gaps in HCC and define clinical research priorities. The CTPM structured its review according to current evidence-based treatment modalities in HCC and prioritized the recommendations on the basis of the patient populations representing the greatest unmet medical need. © 2010 by American Society of Clinical Oncology.
Persistent Identifierhttp://hdl.handle.net/10722/173009
ISSN
2015 Impact Factor: 20.982
2015 SCImago Journal Rankings: 9.204
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorThomas, MBen_US
dc.contributor.authorJaffe, Den_US
dc.contributor.authorChoti, MMen_US
dc.contributor.authorBelghiti, Jen_US
dc.contributor.authorCurley, Sen_US
dc.contributor.authorFong, Yen_US
dc.contributor.authorGores, Gen_US
dc.contributor.authorKerlan, Ren_US
dc.contributor.authorMerle, Pen_US
dc.contributor.authorO'neil, Ben_US
dc.contributor.authorPoon, Ren_US
dc.contributor.authorSchwartz, Len_US
dc.contributor.authorTepper, Jen_US
dc.contributor.authorYao, Fen_US
dc.contributor.authorHaller, Den_US
dc.contributor.authorMooney, Men_US
dc.contributor.authorVenook, Aen_US
dc.date.accessioned2012-10-30T06:26:25Z-
dc.date.available2012-10-30T06:26:25Z-
dc.date.issued2010en_US
dc.identifier.citationJournal Of Clinical Oncology, 2010, v. 28 n. 25, p. 3994-4005en_US
dc.identifier.issn0732-183Xen_US
dc.identifier.urihttp://hdl.handle.net/10722/173009-
dc.description.abstractHepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in adults and the third most common cause of cancer death worldwide. The incidence of HCC in the United States is rising steadily because of the prevalence of hepatitis C viral infection and other causes of hepatic cirrhosis. The majority of patients have underlying hepatic dysfunction, which complicates patient management and the search for safe and effective therapies. The Clinical Trials Planning Meeting (CTPM) in HCC was convened by the National Cancer Institute's Gastrointestinal Cancer Steering Committee to identify the key knowledge gaps in HCC and define clinical research priorities. The CTPM structured its review according to current evidence-based treatment modalities in HCC and prioritized the recommendations on the basis of the patient populations representing the greatest unmet medical need. © 2010 by American Society of Clinical Oncology.en_US
dc.languageengen_US
dc.publisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/en_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.titleHepatocellular carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meetingen_US
dc.typeArticleen_US
dc.identifier.emailPoon, R: poontp@hkucc.hku.hken_US
dc.identifier.authorityPoon, R=rp00446en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1200/JCO.2010.28.7805en_US
dc.identifier.pmid20679622-
dc.identifier.scopuseid_2-s2.0-77957603190en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77957603190&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume28en_US
dc.identifier.issue25en_US
dc.identifier.spage3994en_US
dc.identifier.epage4005en_US
dc.identifier.eissn1527-7755-
dc.identifier.isiWOS:000281502500017-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridThomas, MB=8592491600en_US
dc.identifier.scopusauthoridJaffe, D=35299532900en_US
dc.identifier.scopusauthoridChoti, MM=36569969000en_US
dc.identifier.scopusauthoridBelghiti, J=35403099400en_US
dc.identifier.scopusauthoridCurley, S=7006597814en_US
dc.identifier.scopusauthoridFong, Y=36014058900en_US
dc.identifier.scopusauthoridGores, G=35397007900en_US
dc.identifier.scopusauthoridKerlan, R=7004582506en_US
dc.identifier.scopusauthoridMerle, P=7005472705en_US
dc.identifier.scopusauthoridO'Neil, B=7004515297en_US
dc.identifier.scopusauthoridPoon, R=7103097223en_US
dc.identifier.scopusauthoridSchwartz, L=7402459565en_US
dc.identifier.scopusauthoridTepper, J=7102512734en_US
dc.identifier.scopusauthoridYao, F=7102637912en_US
dc.identifier.scopusauthoridHaller, D=7103258134en_US
dc.identifier.scopusauthoridMooney, M=8242893900en_US
dc.identifier.scopusauthoridVenook, A=7003941063en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats